These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38165047)

  • 1. Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis.
    Abbonante V; Karkempetzaki AI; Leon C; Krishnan A; Huang N; Di Buduo CA; Cattaneo D; Ward CM; Matsuura S; Guinard I; Weber J; De Acutis A; Vozzi G; Iurlo A; Ravid K; Balduini A
    Am J Hematol; 2024 Mar; 99(3):336-349. PubMed ID: 38165047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the mechanotransductor PIEZO1 in megakaryocyte differentiation.
    Demagny J; Poirault-Chassac S; Ilsaint DN; Marchelli A; Gomila C; Ouled-Haddou H; Collet L; Le Guyader M; Gaussem P; Garçon L; Bachelot-Loza C
    J Cell Mol Med; 2024 Sep; 28(18):e70055. PubMed ID: 39304946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
    Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
    PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal role of PDK1 in megakaryocyte cytoskeletal dynamics and polarization during platelet biogenesis.
    Geue S; Aurbach K; Manke MC; Manukjan G; Münzer P; Stegner D; Brähler C; Walker-Allgaier B; Märklin M; Borst CE; Quintanilla-Fend L; Rath D; Geisler T; Salih HR; Seizer P; Lang F; Nieswandt B; Gawaz M; Schulze H; Pleines I; Borst O
    Blood; 2019 Nov; 134(21):1847-1858. PubMed ID: 31578203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional characterization of human megakaryocyte polyploidization and lineage commitment.
    Choudry FA; Bagger FO; Macaulay IC; Farrow S; Burden F; Kempster C; McKinney H; Olsen LR; Huang N; Downes K; Voet T; Uppal R; Martin JF; Mathur A; Ouwehand WH; Laurenti E; Teichmann SA; Frontini M
    J Thromb Haemost; 2021 May; 19(5):1236-1249. PubMed ID: 33587817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
    Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
    Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation.
    Aguilar A; Pertuy F; Eckly A; Strassel C; Collin D; Gachet C; Lanza F; Léon C
    Blood; 2016 Oct; 128(16):2022-2032. PubMed ID: 27503502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin.
    Bhatlekar S; Manne BK; Basak I; Edelstein LC; Tugolukova E; Stoller ML; Cody MJ; Morley SC; Nagalla S; Weyrich AS; Rowley JW; O'Connell RM; Rondina MT; Campbell RA; Bray PF
    Blood; 2020 Oct; 136(15):1760-1772. PubMed ID: 32844999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
    Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
    Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SET domain containing 2 promotes megakaryocyte polyploidization and platelet generation through methylation of α-tubulin.
    Chen L; Liu J; Chen K; Su Y; Chen Y; Lei Y; Si J; Zhang J; Zhang Z; Zou W; Zhang X; Rondina MT; Wang QF; Li Y
    J Thromb Haemost; 2024 Jun; 22(6):1727-1741. PubMed ID: 38537781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation.
    Machlus KR; Wu SK; Stumpo DJ; Soussou TS; Paul DS; Campbell RA; Kalwa H; Michel T; Bergmeier W; Weyrich AS; Blackshear PJ; Hartwig JH; Italiano JE
    Blood; 2016 Mar; 127(11):1468-80. PubMed ID: 26744461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation.
    Raslova H; Baccini V; Loussaief L; Comba B; Larghero J; Debili N; Vainchenker W
    Blood; 2006 Mar; 107(6):2303-10. PubMed ID: 16282343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F.
    Shide K; Shimoda HK; Kumano T; Karube K; Kameda T; Takenaka K; Oku S; Abe H; Katayose KS; Kubuki Y; Kusumoto K; Hasuike S; Tahara Y; Nagata K; Matsuda T; Ohshima K; Harada M; Shimoda K
    Leukemia; 2008 Jan; 22(1):87-95. PubMed ID: 18033315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.
    Mazharian A; Watson SP; Séverin S
    Exp Hematol; 2009 Oct; 37(10):1238-1249.e5. PubMed ID: 19619605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice.
    Barbieri SS; Petrucci G; Tarantino E; Amadio P; Rocca B; Pesce M; Machlus KR; Ranelletti FO; Gianellini S; Weksler B; Italiano JE; Tremoli E
    Thromb Haemost; 2015 Nov; 114(6):1218-29. PubMed ID: 26272103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
    Norfo R; Zini R; Pennucci V; Bianchi E; Salati S; Guglielmelli P; Bogani C; Fanelli T; Mannarelli C; Rosti V; Pietra D; Salmoiraghi S; Bisognin A; Ruberti S; Rontauroli S; Sacchi G; Prudente Z; Barosi G; Cazzola M; Rambaldi A; Bortoluzzi S; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R;
    Blood; 2014 Sep; 124(13):e21-32. PubMed ID: 25097177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't you forget about me(gakaryocytes).
    Tilburg J; Becker IC; Italiano JE
    Blood; 2022 Jun; 139(22):3245-3254. PubMed ID: 34582554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.
    Huang J; Huang S; Ma Z; Lin X; Li X; Huang X; Wang J; Ye W; Li Y; He D; Yang M; Pan J; Ling Q; Li F; Mao S; Wang H; Wang Y; Jin J
    Thromb Haemost; 2021 Feb; 121(2):192-205. PubMed ID: 32961571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
    Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N
    Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.